Growing community of inventors

Cambridge, MA, United States of America

Alan Scott Robertson

Average Co-Inventor Count = 8.00

ph-index = 2

The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.

Forward Citations = 8

Alan Scott RobertsonAngela Marie Cacace (4 patents)Alan Scott RobertsonLorin A Thompson, Iii (4 patents)Alan Scott RobertsonOwen Brendan Wallace (4 patents)Alan Scott RobertsonLucienne V Ronco (4 patents)Alan Scott RobertsonNing Shen (4 patents)Alan Scott RobertsonLuis Gustavo Alejandro Rojas Soto (4 patents)Alan Scott RobertsonAaron Nakwon Chang (4 patents)Alan Scott RobertsonLuis Gustavo Rojas Soto (1 patent)Alan Scott RobertsonLorin A Thompson (1 patent)Alan Scott RobertsonNing Shen (1 patent)Alan Scott RobertsonAngela Marie Cacace (1 patent)Alan Scott RobertsonLorin A Iii Thompson (0 patent)Alan Scott RobertsonAlan Scott Robertson (4 patents)Angela Marie CacaceAngela Marie Cacace (12 patents)Lorin A Thompson, IiiLorin A Thompson, Iii (7 patents)Owen Brendan WallaceOwen Brendan Wallace (7 patents)Lucienne V RoncoLucienne V Ronco (4 patents)Ning ShenNing Shen (4 patents)Luis Gustavo Alejandro Rojas SotoLuis Gustavo Alejandro Rojas Soto (4 patents)Aaron Nakwon ChangAaron Nakwon Chang (4 patents)Luis Gustavo Rojas SotoLuis Gustavo Rojas Soto (1 patent)Lorin A ThompsonLorin A Thompson (1 patent)Ning ShenNing Shen (1 patent)Angela Marie CacaceAngela Marie Cacace (1 patent)Lorin A Iii ThompsonLorin A Iii Thompson (0 patent)
..
Inventor’s number of patents
..
Strength of working relationships

Company Filing History:

1. Fulcrum Therapeutics, Inc. (4 from 8 patents)


4 patents:

1. 11479770 - Use of p38 inhibitors to reduce expression of DUX4

2. 11291659 - P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD

3. 10537560 - P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD

4. 10342786 - P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD

Please report any incorrect information to support@idiyas.com
idiyas.com
as of
12/4/2025
Loading…